Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New EPOC trial of perioperative oxaliplatin/fluoropyrimidine with or without cetuximab for resectable colorectal liver metastases
ISRCTN22944367Phase 3Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Aug 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cetuximab and oxaliplatin in colorectal cancer (CRC) (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Progression-free survival. Started Aug 2006; status: completed.
02
Drugs
cetuximaboxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN22944367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN22944367.